These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8913264)

  • 1. Inhibition of human prostate cancer cells growth by gossypol is associated with stimulation of transforming growth factor-beta.
    Shidaifat F; Canatan H; Kulp SK; Sugimoto Y; Chang WY; Zhang Y; Brueggemeier RW; Somers WJ; Lin YC
    Cancer Lett; 1996 Oct; 107(1):37-44. PubMed ID: 8913264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inhibitory effects of gossypol on human prostate cancer cells-PC3 are associated with transforming growth factor beta1 (TGFbeta1) signal transduction pathway.
    Jiang J; Sugimoto Y; Liu S; Chang HL; Park KY; Kulp SK; Lin YC
    Anticancer Res; 2004; 24(1):91-100. PubMed ID: 15015581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gossypol arrests human benign prostatic hyperplastic cell growth at G0/G1 phase of the cell cycle.
    Shidaifat F; Canatan H; Kulp SK; Sugimoto Y; Zhang Y; Brueggemeier RW; Somers WJ; Chang WY; Wang HC; Lin YC
    Anticancer Res; 1997; 17(2A):1003-9. PubMed ID: 9137441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The (-)-enantiomer of gossypol possesses higher anticancer potency than racemic gossypol in human breast cancer.
    Liu S; Kulp SK; Sugimoto Y; Jiang J; Chang HL; Dowd MK; Wan P; Lin YC
    Anticancer Res; 2002; 22(1A):33-8. PubMed ID: 12017312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of gossypol on O2 consumption and CO2 production in human prostate cancer cells.
    Jiang J; Ghosh PK; Kulp SK; Sugimoto Y; Liu S; Czekajewski J; Chang HL; Lin YC
    Anticancer Res; 2002; 22(3):1491-6. PubMed ID: 12168828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of transforming growth factor beta on human prostate cancer cells in vitro.
    Wilding G; Zugmeier G; Knabbe C; Flanders K; Gelmann E
    Mol Cell Endocrinol; 1989 Mar; 62(1):79-87. PubMed ID: 2545487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gossypol inhibits the growth of MAT-LyLu prostate cancer cells by modulation of TGFbeta/Akt signaling.
    Jiang J; Ye W; Lin YC
    Int J Mol Med; 2009 Jul; 24(1):69-75. PubMed ID: 19513537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of serum on (-)-gossypol-suppressed growth in human prostate cancer cells.
    Huang YW; Wang LS; Chang HL; Ye W; Sugimoto Y; Dowd MK; Wan PJ; Lin YC
    Anticancer Res; 2006; 26(5A):3613-20. PubMed ID: 17094491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of transforming growth factor (TGF) beta1 type II receptor restores TGF-beta1 sensitivity and signaling in human prostate cancer cells.
    Guo Y; Kyprianou N
    Cell Growth Differ; 1998 Feb; 9(2):185-93. PubMed ID: 9486855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of prostatic tumor cell proliferation by suramin: alterations in TGF alpha-mediated autocrine growth regulation and cell cycle distribution.
    Kim JH; Sherwood ER; Sutkowski DM; Lee C; Kozlowski JM
    J Urol; 1991 Jul; 146(1):171-6. PubMed ID: 2056586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gossypol inhibits growth, invasiveness, and angiogenesis in human prostate cancer cells by modulating NF-κB/AP-1 dependent- and independent-signaling.
    Jiang J; Slivova V; Jedinak A; Sliva D
    Clin Exp Metastasis; 2012 Feb; 29(2):165-78. PubMed ID: 22167622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycogen synthesis correlates with androgen-dependent growth arrest in prostate cancer.
    Schnier JB; Nishi K; Gumerlock PH; Gorin FA; Bradbury EM
    BMC Urol; 2005 Mar; 5():6. PubMed ID: 15790394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The (-)-enantiomer of gossypol inhibits proliferation of stromal cells derived from human breast adipose tissues by enhancing transforming growth factor beta1 production.
    Zhang Y; Kulp SK; Sugimoto Y; Brueggemeier RW; Lin YC
    Int J Oncol; 1998 Dec; 13(6):1291-7. PubMed ID: 9824647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lycopene differentially induces quiescence and apoptosis in androgen-responsive and -independent prostate cancer cell lines.
    Ivanov NI; Cowell SP; Brown P; Rennie PS; Guns ES; Cox ME
    Clin Nutr; 2007 Apr; 26(2):252-63. PubMed ID: 17337101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human prostatic cancer cells, PC3, elaborate mitogenic activity which selectively stimulates human bone cells.
    Perkel VS; Mohan S; Herring SJ; Baylink DJ; Linkhart TA
    Cancer Res; 1990 Nov; 50(21):6902-7. PubMed ID: 1698544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gossypol inhibits basal and estrogen-stimulated DNA synthesis in human breast carcinoma cells.
    Hu YF; Chang CJ; Brueggemeier RW; Lin YC
    Life Sci; 1993; 53(25):PL433-8. PubMed ID: 8255144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mammalian target of rapamycin and 3-phosphatidylinositol 3-kinase pathway inhibition enhances growth inhibition of transforming growth factor-beta1 in prostate cancer cells.
    van der Poel HG
    J Urol; 2004 Oct; 172(4 Pt 1):1333-7. PubMed ID: 15371835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of human prostate cancer cell growth by ciprofloxacin is associated with cell cycle arrest and apoptosis.
    Aranha O; Grignon R; Fernandes N; McDonnell TJ; Wood DP; Sarkar FH
    Int J Oncol; 2003 Apr; 22(4):787-94. PubMed ID: 12632069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-proliferative effects of evodiamine on human prostate cancer cell lines DU145 and PC3.
    Kan SF; Yu CH; Pu HF; Hsu JM; Chen MJ; Wang PS
    J Cell Biochem; 2007 May; 101(1):44-56. PubMed ID: 17340628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mediation of glucocorticoid receptor function by transforming growth factor beta I expression in human PC-3 prostate cancer cells.
    Reyes-Moreno C; Frenette G; Boulanger J; Lavergne E; Govindan MV; Koutsilieris M
    Prostate; 1995 May; 26(5):260-9. PubMed ID: 7753711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.